Enhanced antiviral activity of acyclovir loaded into nanoparticles

Area of Science:

• Nanotechnology
• Materials Science
• Pharmacology

Background:

• Antiviral drug efficacy can be improved using advanced delivery systems.
• Polymeric nanoparticles offer potential for targeted drug delivery and enhanced therapeutic outcomes.
• Acyclovir is a key antiviral medication requiring effective delivery strategies.

Purpose of the Study:

• To develop and characterize novel polymeric nanoparticles for acyclovir delivery.
• To evaluate the biocompatibility and cellular trafficking of these nanoparticles.
• To assess the enhanced antiviral activity of acyclovir-loaded nanoparticles.

Main Methods:

• Solvent displacement method for preparing beta-cyclodextrin-poly(4-acryloylmorpholine) (β-CD-PACM) nanoparticles.
• Preparation of fluorescently labeled nanoparticles for cellular studies.
• Biocompatibility assays and assessment of antiviral activity.

Main Results:

• Successful preparation of acyclovir-loaded β-CD-PACM nanoparticles.
• Demonstration of nanoparticle biocompatibility for safe application.
• Preliminary assessment indicating potential for enhanced antiviral activity.

Conclusions:

• β-CD-PACM nanoparticles represent a promising system for acyclovir delivery.
• The developed nanoparticles show potential for improved antiviral therapy.
• Further studies are warranted to fully elucidate the therapeutic benefits.